文献检索/Expert Opinion on Drug SafetyEM-T3Expert Opinion on Drug Safety2021-01-04第 20 卷第 6 期，1-13开放获取高影响力 · 前 10%A long-term open-label safety study of galcanezumab in Japanese patients with migraineKoichi HirataDokkyo Medical University HospitalTakao TakeshimaTominaga hospitalFumihiko SakaiSaitama Neuropsychiatric InstituteYoshihisa TatsuokaNorihiro SuzukiShonan Keiiku HospitalHisaka IgarashiFujitsu (Japan)Tomomi NakamuraEli Lilly (Japan)Akichika OzekiEli Lilly (Japan)Hiroyoshi YamazakiEli Lilly (Japan)Vladimir SkljarevskiEli Lilly (United States)去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词galcanezumabmigraineepisodic migrainechronic migrainemigraine prophylaxislong-term safetytolerabilityJapanese patientsnasopharyngitisinjection site reactionstreatment discontinuationheadache days参考文献34引证文献1相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
